FBTCX vs. SHSSX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Health Sciences Opportunities Fund Class Institutional (SHSSX).
FBTCX is managed by Fidelity. It was launched on Dec 27, 2000. SHSSX is a passively managed fund by BlackRock that tracks the performance of the Russell 3000 HealthCare Index. It was launched on Oct 16, 2000.
Performance
FBTCX vs. SHSSX - Performance Comparison
Loading graphics...
FBTCX vs. SHSSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBTCX Fidelity Advisor Biotechnology Fund Class C | -2.86% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 24.82% | -4.55% | 24.81% |
SHSSX Health Sciences Opportunities Fund Class Institutional | -6.87% | 16.13% | 4.00% | 3.86% | -5.72% | 12.17% | 19.54% | 25.63% | 8.24% | 25.02% |
Returns By Period
In the year-to-date period, FBTCX achieves a -2.86% return, which is significantly higher than SHSSX's -6.87% return. Both investments have delivered pretty close results over the past 10 years, with FBTCX having a 9.77% annualized return and SHSSX not far ahead at 9.97%.
FBTCX
- 1D
- -0.75%
- 1M
- -6.13%
- YTD
- -2.86%
- 6M
- 10.98%
- 1Y
- 41.66%
- 3Y*
- 15.08%
- 5Y*
- 5.77%
- 10Y*
- 9.77%
SHSSX
- 1D
- 0.31%
- 1M
- -9.09%
- YTD
- -6.87%
- 6M
- 4.09%
- 1Y
- 4.34%
- 3Y*
- 6.17%
- 5Y*
- 4.28%
- 10Y*
- 9.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTCX vs. SHSSX - Expense Ratio Comparison
FBTCX has a 1.75% expense ratio, which is higher than SHSSX's 0.84% expense ratio.
Return for Risk
FBTCX vs. SHSSX — Risk / Return Rank
FBTCX
SHSSX
FBTCX vs. SHSSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and Health Sciences Opportunities Fund Class Institutional (SHSSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBTCX | SHSSX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.52 | 0.29 | +1.23 |
Sortino ratioReturn per unit of downside risk | 2.06 | 0.52 | +1.54 |
Omega ratioGain probability vs. loss probability | 1.26 | 1.06 | +0.20 |
Calmar ratioReturn relative to maximum drawdown | 2.31 | 0.43 | +1.88 |
Martin ratioReturn relative to average drawdown | 9.25 | 1.02 | +8.23 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBTCX | SHSSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.52 | 0.29 | +1.23 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.25 | 0.30 | -0.06 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.61 | -0.21 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.69 | -0.42 |
Correlation
The correlation between FBTCX and SHSSX is 0.81, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FBTCX vs. SHSSX - Dividend Comparison
FBTCX's dividend yield for the trailing twelve months is around 1.73%, less than SHSSX's 10.63% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.73% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
SHSSX Health Sciences Opportunities Fund Class Institutional | 10.63% | 9.90% | 8.68% | 3.82% | 7.20% | 8.96% | 4.18% | 3.87% | 8.44% | 3.59% | 2.33% | 12.29% |
Drawdowns
FBTCX vs. SHSSX - Drawdown Comparison
The maximum FBTCX drawdown since its inception was -64.04%, which is greater than SHSSX's maximum drawdown of -35.40%. Use the drawdown chart below to compare losses from any high point for FBTCX and SHSSX.
Loading graphics...
Drawdown Indicators
| FBTCX | SHSSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.04% | -35.40% | -28.64% |
Max Drawdown (1Y)Largest decline over 1 year | -13.63% | -9.83% | -3.80% |
Max Drawdown (5Y)Largest decline over 5 years | -37.26% | -17.90% | -19.36% |
Max Drawdown (10Y)Largest decline over 10 years | -39.37% | -28.34% | -11.03% |
Current DrawdownCurrent decline from peak | -7.46% | -9.56% | +2.10% |
Average DrawdownAverage peak-to-trough decline | -23.21% | -5.98% | -17.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.16% | 4.17% | -0.01% |
Volatility
FBTCX vs. SHSSX - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a higher volatility of 7.76% compared to Health Sciences Opportunities Fund Class Institutional (SHSSX) at 4.61%. This indicates that FBTCX's price experiences larger fluctuations and is considered to be riskier than SHSSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBTCX | SHSSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.76% | 4.61% | +3.15% |
Volatility (6M)Calculated over the trailing 6-month period | 16.37% | 9.73% | +6.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.57% | 16.32% | +9.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.40% | 14.19% | +9.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.62% | 16.53% | +8.09% |